Prescription of Valproate and Derivatives in Women of Childbearing Age: Qualitative Study
This study is investigating the prescription of a medication called valproate to women who are of childbearing age, meaning they could get pregnant. Valproate is used for conditions like mood disorders. There are concerns because taking valproate during pregnancy can cause serious problems for the baby, including birth defects and developmental issues like autism or learning difficulties. Even though doctors in France have greatly reduced its use in these women, and there have been various warnings, some women still receive it. The study wants to understand why this is happening and why babies are still being born to mothers taking valproate, highlighting the ongoing risks associated with this medication during pregnancy.
At a glance
What is this study about?
This research is looking into how a medicine called valproate is prescribed to women who are old enough to have children. Valproate is used to treat certain mental health conditions, like mood disorders. Over recent years, doctors in France have become much more careful about giving this medicine to women who might get pregnant because there are significant concerns about its effects on unborn babies.
Taking valproate during pregnancy can lead to serious problems for the baby. These can include physical birth defects affecting different parts of the body, and also developmental problems. This means the child might have difficulties with things like learning, attention (like ADHD), communication, or how they move. These issues can affect their education and social skills later in life. Despite warnings and a big drop in prescriptions, the study notes that some women in France are still taking valproate when they become pregnant.
The main goal of this study is to understand why this is still happening. By looking at existing medical records, researchers hope to get a clearer picture of how valproate is being used. This information could help doctors and healthcare providers make sure that women are fully aware of the risks and receive the safest possible treatment options, especially if they are considering starting a family.
Key takeaways
- This study investigates valproate prescriptions for women of childbearing age.
- Valproate can cause significant risks to babies if taken during pregnancy.
- The research aims to understand why some women still receive valproate despite warnings.
- It uses existing medical records, so no new appointments or treatments are involved.
- The findings could help improve patient safety and prescribing practices.
Who may be eligible?
To be included in this study, participants must be at least 16 years old and female. They must have been prescribed valproate or a similar medication (like Sodium Divalproate, Valpromide, Valproic Acid, or Sodium Valproate) for a mental health condition between January 1, 2021, and December 31, 2022.
Participants also need to agree to their existing medical information being used for this research after they've been given all the necessary details. If a participant is under 18, their parent or legal guardian must also agree for their child's information to be used.
You would not be able to take part in this study if you, or your parent/guardian (if applicable), have said that you don't want to be involved. Also, if there are difficulties that would make it impossible to properly explain the study to you and get your informed agreement, you would not be able to participate. This study uses existing medical records and doesn't involve any new treatments or doctor's appointments.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you female and aged 16 or older?
- Were you prescribed valproate (or similar medication) for a mental health condition between Jan 2021 and Dec 2022?
- Are you happy for researchers to look at your past medical records?
- Have you *not* previously said you don't want to be in the study?
What does participation involve?
Taking part in this study would involve allowing researchers to look at your existing medical records. You wouldn't need to attend any extra appointments or take any new medications. You wouldn't be asked to do anything different in your daily life. The study simply involves checking information already held in your medical files between January 1, 2021, and December 31, 2022, to understand prescribing patterns for valproate. You would not have any direct interaction with the research team beyond giving your permission for your data to be used.
Potential risks and benefits
Locations (1)
- Service de Psychiatrie 2 - CHU de Strasbourg - FranceVerified postcodeStrasbourg, France· Recruiting
Common questions
What is valproate?
Valproate is a medicine used to treat certain mental health conditions, like mood disorders and epilepsy.
Why are doctors concerned about valproate and pregnancy?
Taking valproate during pregnancy can significantly increase the risk of serious problems for the baby, including birth defects and developmental issues like autism or learning difficulties.
Will I have to take new medicine or visit the hospital?
No, this study only looks at your existing medical records. You won't need to take any new medicine or attend any extra appointments.
Is my personal information safe in this study?
Yes, your personal information will be kept private and handled securely. The study focuses on patterns, not individual identities.
Can I change my mind about participating?
Yes, you have the right to withdraw your permission for your medical data to be used in this study at any time.
How to find out more
Sébastien WEIBEL, MD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.